BIOMARKER FOR RHEUMATOID ARTHRITIS DIAGNOSIS OR ACTIVITY EVALUATION
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Sep 22, 2016
app pub date -
Jun 20, 2014
filing date -
Jun 20, 2014
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
The present invention relates to a composition and kit for rheumatoid arthritis diagnosis or activity evaluation, the composition and kit each including an agent for measuring the concentration of at least one protein selected from a group consisting of soluble CD14 (sCD14), a-1-acid glycoprotein 1 (AGP1), and a-1-acid glycoprotein 2 (AGP2). Further, the present invention relates to a use of the composition for diagnosing rheumatoid arthritis or evaluating activity.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully